Patterns of recurrence in triple negative breast cancer patients After this high-risk period, the likelihood of a relapse declines and eventually becomes lower than that of hormone receptor positive (ER+ PR+) breast cancer Triple negative breast cancer survivors are also more likely to develop new tumors in the opposite breast (contralateral breast cancer)
Triple-Negative Breast Cancer: Prognosis and Survival Rates The risk of the cancer returning rises sharply after diagnosis, peaks between years one and three, and then drops quickly After about three years, the recurrence risk plateaus and remains relatively stable
Characteristics of recurrence, predictors for relapse and prognosis of . . . Triple-negative breast cancer (TNBC) patients who recur at different times are associated with distinct biological characteristics and prognoses Research on rapid-relapse TNBC (RR-TNBC) is sparse In this study, we aimed to describe the
TNBC Recurrence: Risks, Symptoms Treatment Options Triple-negative breast cancer recurrence is most common in the first 3–5 years Understand types, symptoms, risk factors, and current treatment options
Triple-Negative Recurrence After PCR: Risk and Prognosis Despite achieving PCR, a subset of TNBC patients experience disease recurrence Reported incidence varies, with estimates ranging from 10% to 30% within five years, depending on tumor stage, treatment regimen, and follow-up duration